ARCHIVES

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

ONS Adopts Position Statement On Rehabilitation

May 5, 1989

Barnett Kramer Next Director Of NCI Division of Cancer Prevention

July 29, 2011

Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected

October 1, 1976

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

ORI Instructs NSAB to Prepare for Investigation

April 19, 1996

Letter to the Editors: Since 1992, Where Has All The OAM Grant Money Gone?

April 24, 1998